Drug intelligence / Profile preview

Compound Kushen Gel

Development stage
Phase 3
Lead developer
Guiyang Xintian Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Vaginal
01

Overview

Compound Kushen Gel (复方苦参凝胶) is an investigational Class 1.1 traditional Chinese medicine (TCM) innovative drug formulated as a topical vaginal gel. Developed by Guiyang Xintian Pharmaceutical and Shandong University of Traditional Chinese Medicine, the formulation is designed to clear heat, dry dampness, kill parasites, and relieve itching (清热燥湿,杀虫止痒). It is currently in Phase III clinical trials in China for the treatment of adult non-menopausal women with bacterial vaginosis who present with the TCM syndrome of damp-heat downward flow (湿热下注证).

Other names
003 project003项目复方苦参凝胶
02

Targets

CASP3 (Caspase-3)CDK1 (Cyclin-dependent kinase 1)CDK2 (Cyclin-dependent kinase 2)CHRNA3 (nAChR α3 subunit)CHRNA5 (Nicotinic acetylcholine receptor alpha-5 subunit)DRD2 (Dopamine D2 Receptor)HPV16 E6 oncoproteinMMP1 (Matrix metalloproteinase-1)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)MYC (MYC proto-oncogene protein)MYD88 (Myeloid differentiation primary response protein MyD88)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)PLG (Plasminogen)PRKCA (Protein kinase C alpha)SCN9A (Sodium channel protein type 9 subunit alpha)TLR9 (Toll-like receptor 9)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Compound Kushen Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Kushen Gel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call